标题
Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics
作者
关键词
-
出版物
OncoImmunology
Volume 6, Issue 12, Pages e1386829
出版商
Informa UK Limited
发表日期
2017-10-05
DOI
10.1080/2162402x.2017.1386829
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Association Between High-Avidity T-Cell Receptors, Induced by α-Fetoprotein−Derived Peptides, and Anti-Tumor Effects in Patients With Hepatocellular Carcinoma
- (2017) Hidetoshi Nakagawa et al. GASTROENTEROLOGY
- Identification of Natural Regulatory T Cell Epitopes Reveals Convergence on a Dominant Autoantigen
- (2017) John D. Leonard et al. IMMUNITY
- The role of CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in complement-mediated phagocytosis and podosome formation by human phagocytes
- (2017) Szilvia Lukácsi et al. IMMUNOLOGY LETTERS
- Treg depletion potentiates checkpoint inhibition in claudin-low breast cancer
- (2017) Nicholas A. Taylor et al. JOURNAL OF CLINICAL INVESTIGATION
- TNF superfamily receptor OX40 triggers invariant NKT cell pyroptosis and liver injury
- (2017) Peixiang Lan et al. JOURNAL OF CLINICAL INVESTIGATION
- Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis
- (2017) Samra Turajlic et al. LANCET ONCOLOGY
- MK2 Phosphorylates RIPK1 to Prevent TNF-Induced Cell Death
- (2017) Isabel Jaco et al. MOLECULAR CELL
- cGAS surveillance of micronuclei links genome instability to innate immunity
- (2017) Karen J. Mackenzie et al. NATURE
- Mitotic progression following DNA damage enables pattern recognition within micronuclei
- (2017) Shane M. Harding et al. NATURE
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
- (2017) Marian L. Burr et al. NATURE
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- miR-25/93 mediates hypoxia-induced immunosuppression by repressing cGAS
- (2017) Min-Zu Wu et al. NATURE CELL BIOLOGY
- Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles
- (2017) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma
- (2017) Michel Attal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic biomarker for cancer immunotherapy
- (2017) Sangeeta Goswami et al. SCIENCE
- Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy
- (2017) Teresa Davoli et al. SCIENCE
- Blockade of surface-bound TGF-β on regulatory T cells abrogates suppression of effector T cell function in the tumor microenvironment
- (2017) Sadna Budhu et al. Science Signaling
- A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
- (2017) Donald M. O’Rourke et al. Science Translational Medicine
- Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape
- (2017) Abhishek D. Garg et al. TRENDS IN IMMUNOLOGY
- DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
- (2017) Claire Vanpouille-Box et al. Nature Communications
- Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment
- (2017) Oladapo O. Yeku et al. Scientific Reports
- The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy
- (2017) Daniel Zingg et al. Cell Reports
- Blockade of surface-bound TGF-β on regulatory T cells abrogates suppression of effector T cell function in the tumor microenvironment
- (2017) Sadna Budhu et al. Science Signaling
- Using Antigen-Specific B Cells to Combine Antibody and T Cell–Based Cancer Immunotherapy
- (2017) Kerstin Wennhold et al. Cancer Immunology Research
- Barriers to Radiation-Induced In Situ Tumor Vaccination
- (2017) Erik Wennerberg et al. Frontiers in Immunology
- Langerhans cells and NK cells cooperate in the inhibition of chemical skin carcinogenesis
- (2017) Daniela Ortner et al. OncoImmunology
- Dosing immunotherapy combinations: Analysis of 3,526 patients for toxicity and response patterns
- (2017) Mina Nikanjam et al. OncoImmunology
- Generation and functional characterization of MDSC-like cells
- (2017) Annkristin Heine et al. OncoImmunology
- Preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma
- (2017) Abhishek D. Garg et al. OncoImmunology
- Trial watch: Dendritic cell-based anticancer immunotherapy
- (2017) Abhishek D. Garg et al. OncoImmunology
- The safety, efficacy, and treatment outcomes of a combination of low-dose decitabine treatment in patients with recurrent ovarian cancer
- (2017) Yan Zhang et al. OncoImmunology
- Preclinical immunoPET/CT imaging using Zr-89-labeled anti-PD-L1 monoclonal antibody for assessing radiation-induced PD-L1 upregulation in head and neck cancer and melanoma
- (2017) Masahiro Kikuchi et al. OncoImmunology
- Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activation
- (2017) Rūta Veinalde et al. OncoImmunology
- Co-delivery of the NKT agonist α-galactosylceramide and tumor antigens to cross-priming dendritic cells breaks tolerance to self-antigens and promotes antitumor responses
- (2017) Reem Ghinnagow et al. OncoImmunology
- Tumor-infiltrating neutrophils predict benefit from adjuvant chemotherapy in patients with muscle invasive bladder cancer
- (2017) Lin Zhou et al. OncoImmunology
- Inhibition of Transforming Growth Factor-β Activation Diminishes Tumor Progression and Osteolytic Bone Disease in Mouse Models of Multiple Myeloma
- (2016) Ailing Lu et al. AMERICAN JOURNAL OF PATHOLOGY
- Extended Tumor Control after Dendritic Cell Vaccination with Low-Dose Cyclophosphamide as Adjuvant Treatment in Patients with Malignant Pleural Mesothelioma
- (2016) Robin Cornelissen et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Randomized phase 2 study: elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM
- (2016) A. Jakubowiak et al. BLOOD
- Randomized multicenter phase 2 study of pomalidomide, cyclophosphamide, and dexamethasone in relapsed refractory myeloma
- (2016) Rachid C. Baz et al. BLOOD
- Randomized phase 2 trial of ixazomib and dexamethasone in relapsed multiple myeloma not refractory to bortezomib
- (2016) S. K. Kumar et al. BLOOD
- Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single-center, open-label, phase 2 study
- (2016) Pat Gulhati et al. CANCER
- Bevacizumab combined with docetaxel, oxaliplatin, and capecitabine, followed by maintenance with capecitabine and bevacizumab, as first-line treatment of patients with advanced HER2-negative gastric cancer: A multicenter phase 2 study
- (2016) Didier Meulendijks et al. CANCER
- A phase 1 dose-escalation study of filanesib plus bortezomib and dexamethasone in patients with recurrent/refractory multiple myeloma
- (2016) Ajai Chari et al. CANCER
- Final overall survival results of a randomized trial comparing bortezomib plus pegylated liposomal doxorubicin with bortezomib alone in patients with relapsed or refractory multiple myeloma
- (2016) Robert Z. Orlowski et al. CANCER
- Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance
- (2016) Federico Pietrocola et al. CANCER CELL
- Fasting-Mimicking Diet Reduces HO-1 to Promote T Cell-Mediated Tumor Cytotoxicity
- (2016) Stefano Di Biase et al. CANCER CELL
- Intraperitoneal immunotherapy: historical perspectives and modern therapy
- (2016) W F Morano et al. CANCER GENE THERAPY
- Immunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translation
- (2016) A D Garg et al. CELL DEATH AND DIFFERENTIATION
- Regulated cell death and adaptive stress responses
- (2016) Lorenzo Galluzzi et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Prognostic Significance of Monocytes and Monocytic Myeloid-Derived Suppressor Cells in Diffuse Large B-Cell Lymphoma Treated with R-CHOP
- (2016) Chongyang Wu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Genomic Approaches to Understanding Response and Resistance to Immunotherapy
- (2016) D. A. Braun et al. CLINICAL CANCER RESEARCH
- Integrative Development of a TLR8 Agonist for Ovarian Cancer Chemoimmunotherapy
- (2016) Bradley J. Monk et al. CLINICAL CANCER RESEARCH
- Mutational Landscape and Sensitivity to Immune Checkpoint Blockers
- (2016) R. M. Chabanon et al. CLINICAL CANCER RESEARCH
- Phase I clinical trial of a five-peptide cancer vaccine combined with cyclophosphamide in advanced solid tumors
- (2016) Mutsunori Murahashi et al. CLINICAL IMMUNOLOGY
- Learning from the “tsunami” of immune checkpoint inhibitors in 2015
- (2016) Hampig Raphael Kourie et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Chemotherapy and immunotherapy: mapping the road ahead
- (2016) Alistair M Cook et al. CURRENT OPINION IN IMMUNOLOGY
- Generating long-lived CD8+T-cell memory: Insights from epigenetic programs
- (2016) Pranay Dogra et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Immunological effects of chemotherapy and radiotherapy against brain tumors
- (2016) Tobias Weiss et al. Expert Review of Anticancer Therapy
- Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy
- (2016) Christina Pfirschke et al. IMMUNITY
- The memory of a killer T cell: models of CD8+ T cell differentiation
- (2016) Bram Gerritsen et al. IMMUNOLOGY AND CELL BIOLOGY
- Target Density, Not Affinity or Avidity of Antigen Recognition, Determines Adoptive T Cell Therapy Outcomes in a Mouse Lymphoma Model
- (2016) Gabriela Segal et al. JOURNAL OF IMMUNOLOGY
- Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial
- (2016) William D Tap et al. LANCET
- Dexrazoxane improves cardiac autonomic function in epirubicin-treated breast cancer patients with type 2 diabetes
- (2016) Fangyi Sun et al. MEDICINE
- Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma
- (2016) I. Buondonno et al. MOLECULAR CANCER THERAPEUTICS
- Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy
- (2016) Lorenzo Galluzzi et al. Nature Reviews Clinical Oncology
- Necroptosis in development, inflammation and disease
- (2016) Ricardo Weinlich et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
- (2016) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Damage-associated molecular patterns in cancer: a double-edged sword
- (2016) C Hernandez et al. ONCOGENE
- Influence of R-CHOP Therapy on Immune System Restoration in Patients with B-Cell Lymphoma
- (2016) Kaori Ito et al. ONCOLOGY
- The "cancer immunogram"
- (2016) C. U. Blank et al. SCIENCE
- Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell–driven rejection of high-grade glioma
- (2016) Abhishek D. Garg et al. Science Translational Medicine
- Metabolic pathways in T cell activation and lineage differentiation
- (2016) Luís Almeida et al. SEMINARS IN IMMUNOLOGY
- More to Life than NF-κB in TNFR1 Signaling
- (2016) Adrian T. Ting et al. TRENDS IN IMMUNOLOGY
- Extracellular ATP and P2X7 receptor exert context-specific immunogenic effects after immunogenic cancer cell death
- (2016) A D Garg et al. Cell Death & Disease
- The miR-27a-calreticulin axis affects drug-induced immunogenic cell death in human colorectal cancer cells
- (2016) T Colangelo et al. Cell Death & Disease
- Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy
- (2016) S. J. Blake et al. Cancer Discovery
- Distinct Transcriptional Programs Control Cross-Priming in Classical and Monocyte-Derived Dendritic Cells
- (2016) Carlos G. Briseño et al. Cell Reports
- Immunological Mechanisms Underneath the Efficacy of Cancer Therapy
- (2016) L. Galluzzi et al. Cancer Immunology Research
- TCR Sequencing Can Identify and Track Glioma-Infiltrating T Cells after DC Vaccination
- (2016) M. S. Hsu et al. Cancer Immunology Research
- Endogenous Neoantigen-Specific CD8 T Cells Identified in Two Glioblastoma Models Using a Cancer Immunogenomics Approach
- (2016) T. M. Johanns et al. Cancer Immunology Research
- Prognostic value of HMGB1 in early breast cancer patients under neoadjuvant chemotherapy
- (2016) Ruth Exner et al. Cancer Medicine
- Editorial: Immunogenic Cell Death in Cancer: From Benchside Research to Bedside Reality
- (2016) Abhishek D. Garg et al. Frontiers in Immunology
- The transcriptome of lung tumor-infiltrating dendritic cells reveals a tumor-supporting phenotype and a microRNA signature with negative impact on clinical outcome
- (2016) Lotte Pyfferoen et al. OncoImmunology
- Leukocytes recruited by tumor-derived HMGB1 sustain peritoneal carcinomatosis
- (2016) Lucia Cottone et al. OncoImmunology
- Myeloid PTEN deficiency impairs tumor-immune surveillance via immune-checkpoint inhibition
- (2016) M. Kuttke et al. OncoImmunology
- Human CD1c+ DCs are critical cellular mediators of immune responses induced by immunogenic cell death
- (2016) Stefania Di Blasio et al. OncoImmunology
- Prophylactic use of low-dose interleukin-2 and the clinical outcomes of hematopoietic stem cell transplantation: A randomized study
- (2016) Xiang-Yu Zhao et al. OncoImmunology
- mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma
- (2016) Troels Holz Borch et al. OncoImmunology
- Ipilimumab administered to metastatic melanoma patients who progressed after dendritic cell vaccination
- (2016) Steve Boudewijns et al. OncoImmunology
- Chemotherapy and immunotherapy: A close interplay to fight cancer?
- (2016) Aurélie Hanoteau et al. OncoImmunology
- Intratumoral natural killer cells show reduced effector and cytolytic properties and control the differentiation of effector Th1 cells
- (2016) Sourav Paul et al. OncoImmunology
- Immune contexture and histological response after neoadjuvant chemotherapy predict clinical outcome of lung cancer patients
- (2016) Romain Remark et al. OncoImmunology
- Results of a phase I–II study of adjuvant concurrent carboplatin and accelerated radiotherapy for triple negative breast cancer
- (2016) Silvia C. Formenti et al. OncoImmunology
- Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients
- (2016) Steve Boudewijns et al. OncoImmunology
- Characterization of cytokinome landscape for clinical responses in human cancers
- (2016) Henry Sung-Ching Wong et al. OncoImmunology
- Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy
- (2016) Heng Yang et al. OncoImmunology
- Current tools for predicting cancer-specific T cell immunity
- (2016) David Gfeller et al. OncoImmunology
- Clinical impact of chemotherapy to improve tumor microenvironment of pancreatic cancer
- (2016) Takahiro Tsuchikawa et al. World Journal of Gastrointestinal Oncology
- Induction of Immunogenic Cell Death by Chemotherapeutic Platinum Complexes
- (2015) Daniel Yuan Qiang Wong et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Obinutuzumab plus fludarabine/cyclophosphamide or bendamustine in the initial therapy of CLL patients: the phase 1b GALTON trial
- (2015) Jennifer R. Brown et al. BLOOD
- Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia
- (2015) D. Rossi et al. BLOOD
- Frontline rituximab, cyclophosphamide, doxorubicin, and prednisone with bortezomib (VR-CAP) or vincristine (R-CHOP) for non-GCB DLBCL
- (2015) F. Offner et al. BLOOD
- Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenstrom macroglobulinemia: final analysis of a phase 2 study
- (2015) E. Kastritis et al. BLOOD
- A phase 2 study of weekly temsirolimus and bortezomib for relapsed or refractory B-cell non-Hodgkin lymphoma: A Wisconsin Oncology Network study
- (2015) Timothy S. Fenske et al. CANCER
- Fludarabine, cyclophosphamide, and multiple-dose rituximab as frontline therapy for chronic lymphocytic leukemia
- (2015) Nicholas J. Short et al. CANCER
- Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-typeKRASadvanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study)
- (2015) Francesco Leone et al. CANCER
- Low-dose cyclophosphamide enhances antigen-specific CD4+ T cell responses to NY-ESO-1/ISCOMATRIX™ vaccine in patients with advanced melanoma
- (2015) Oliver Klein et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions
- (2015) Yannick Willemen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- STAT3 Inhibition Enhances the Therapeutic Efficacy of Immunogenic Chemotherapy by Stimulating Type 1 Interferon Production by Cancer Cells
- (2015) Heng Yang et al. CANCER RESEARCH
- Identification of Rare High-Avidity, Tumor-Reactive CD8+ T Cells by Monomeric TCR-Ligand Off-Rates Measurements on Living Cells
- (2015) M. Hebeisen et al. CANCER RESEARCH
- Melphalan, Antimelanoma Immunity, and Inflammation--Response
- (2015) A. D. Garg et al. CANCER RESEARCH
- Antitumor Immunity Triggered by Melphalan Is Potentiated by Melanoma Cell Surface-Associated Calreticulin
- (2015) A. M. Dudek-Peri et al. CANCER RESEARCH
- Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
- (2015) Padmanee Sharma et al. CELL
- Canonical Inflammasomes Drive IFN-γ to Prime Caspase-11 in Defense against a Cytosol-Invasive Bacterium
- (2015) Youssef Aachoui et al. Cell Host & Microbe
- RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors
- (2015) S. Loi et al. CLINICAL CANCER RESEARCH
- Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells
- (2015) G. Schreibelt et al. CLINICAL CANCER RESEARCH
- Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983
- (2015) Erik Tanis et al. EUROPEAN JOURNAL OF CANCER
- Immunogenic cell death
- (2015) Abhishek D. Garg et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- Immunosurveillance and therapy of multiple myeloma are CD226 dependent
- (2015) Camille Guillerey et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor neoantigens: building a framework for personalized cancer immunotherapy
- (2015) Matthew M. Gubin et al. JOURNAL OF CLINICAL INVESTIGATION
- Cish actively silences TCR signaling in CD8 + T cells to maintain tumor tolerance
- (2015) Douglas C. Palmer et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Trastuzumab Triggers Phagocytic Killing of High HER2 Cancer Cells In Vitro and In Vivo by Interaction with Fcγ Receptors on Macrophages
- (2015) Yun Shi et al. JOURNAL OF IMMUNOLOGY
- Genetic Vaccines To Potentiate the Effective CD103+Dendritic Cell–Mediated Cross-Priming of Antitumor Immunity
- (2015) Yi Zhang et al. JOURNAL OF IMMUNOLOGY
- Specific Roles of Each TCR Hemichain in Generating Functional Chain-Centric TCR
- (2015) Munehide Nakatsugawa et al. JOURNAL OF IMMUNOLOGY
- Activated NKT Cells Can Condition Different Splenic Dendritic Cell Subsets To Respond More Effectively to TLR Engagement and Enhance Cross-Priming
- (2015) Taryn L. Osmond et al. JOURNAL OF IMMUNOLOGY
- Affinity maturation of T-cell receptor-like antibodies for Wilms tumor 1 peptide greatly enhances therapeutic potential
- (2015) Q Zhao et al. LEUKEMIA
- FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas
- (2015) P J Brown et al. LEUKEMIA
- X-shaped DNA potentiates therapeutic efficacy in colitis-associated colon cancer through dual activation of TLR9 and inflammasomes
- (2015) Jung Eun Koo et al. Molecular Cancer
- Paradigm shift in oncology: targeting the immune system rather than cancer cells
- (2015) T. Shekarian et al. MUTAGENESIS
- Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy
- (2015) Shabnam Shalapour et al. NATURE
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- Necroptosis and its role in inflammation
- (2015) Manolis Pasparakis et al. NATURE
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bortezomib-Based Therapy for Newly Diagnosed Mantle-Cell Lymphoma
- (2015) Tadeusz Robak et al. NEW ENGLAND JOURNAL OF MEDICINE
- A long non-coding RNA links calreticulin-mediated immunogenic cell removal to RB1 transcription
- (2015) A-S Musahl et al. ONCOGENE
- Dendritic cells require NIK for CD40-dependent cross-priming of CD8+T cells
- (2015) Anand K. Katakam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neo approaches to cancer vaccines
- (2015) L. Delamarre et al. SCIENCE
- RIPK1 and NF- B signaling in dying cells determines cross-priming of CD8+ T cells
- (2015) N. Yatim et al. SCIENCE
- Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
- (2015) E. M. Van Allen et al. SCIENCE
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1
- (2015) E. Vacchelli et al. SCIENCE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- First clinical results of a personalized immunotherapeutic vaccine against recurrent, incompletely resected, treatment-resistant glioblastoma multiforme (GBM) tumors, based on combined allo- and auto-immune tumor reactivity
- (2015) Virgil E.J.C. Schijns et al. VACCINE
- Enhancement of adoptive T cell transfer with single low dose pretreatment of doxorubicin or paclitaxel in mice
- (2015) Fei-Ting Hsu et al. Oncotarget
- Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal
- (2015) Abhishek D. Garg et al. Oncotarget
- Bortezomib enhances expression of effector molecules in anti-tumor CD8+ T lymphocytes by promoting Notch-nuclear factor-κB crosstalk
- (2015) Menaka C. Thounaojam et al. Oncotarget
- Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy
- (2015) Erika Vacchelli et al. Oncotarget
- Transpresentation of interleukin‑15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity
- (2015) Johan Van den Bergh et al. Oncotarget
- Rituximab-induced HMGB1 release is associated with inhibition of STAT3 activity in human diffuse large B-cell lymphoma
- (2015) Tiansuo Zhao et al. Oncotarget
- Treatment of Systemic Necrotizing Vasculitides in Patients Aged Sixty-Five Years or Older: Results of a Multicenter, Open-Label, Randomized Controlled Trial of Corticosteroid and Cyclophosphamide-Based Induction Therapy
- (2015) Christian Pagnoux et al. Arthritis & Rheumatology
- Identification and Characterization of MEDI4736, an Antagonistic Anti-PD-L1 Monoclonal Antibody
- (2015) R. Stewart et al. Cancer Immunology Research
- Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies
- (2015) E. E. Evans et al. Cancer Immunology Research
- Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death
- (2015) Abhishek D. Garg et al. Frontiers in Immunology
- DAMPs from Cell Death to New Life
- (2015) Emilie Vénéreau et al. Frontiers in Immunology
- Doxil Synergizes with Cancer Immunotherapies to Enhance Antitumor Responses in Syngeneic Mouse Models
- (2015) Jonathan Rios-Doria et al. NEOPLASIA
- Can dendritic cells improve whole cancer cell vaccines based on immunogenically killed cancer cells?
- (2015) Laetitia Cicchelero et al. OncoImmunology
- Mast cell/MDSC a liaison immunosuppressive for tumor microenvironment
- (2015) Luca Danelli et al. OncoImmunology
- Metronomic cyclophosphamide eradicates large implanted GL261 gliomas by activating antitumor Cd8+T-cell responses and immune memory
- (2015) Junjie Wu et al. OncoImmunology
- Natural killer cell mediated immunosurveillance of pediatric neuroblastoma
- (2015) Michaela Semeraro et al. OncoImmunology
- Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy
- (2015) Kristina Iribarren et al. OncoImmunology
- Rapid generation of NY-ESO-1-specific CD4+THELPER1 cells for adoptive T-cell therapy
- (2015) Simone Kayser et al. OncoImmunology
- PD-1 expression on dendritic cells suppresses CD8+ T cell function and antitumor immunity
- (2015) Tong Seng Lim et al. OncoImmunology
- Human mesothelioma induces defects in dendritic cell numbers and antigen-processing function which predict survival outcomes
- (2015) Scott M.J. Cornwall et al. OncoImmunology
- Immunogenic cell death-related biomarkers: Impact on the survival of breast cancer patients after adjuvant chemotherapy
- (2015) Sylvain Ladoire et al. OncoImmunology
- Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer
- (2015) Simona Bramante et al. OncoImmunology
- All that glitters is not gold: the need to consider desirable and undesirable immune aspects of oncolytic virus therapy
- (2015) Derek R Clements et al. OncoImmunology
- Cancer associated fibroblasts have phenotypic and functional characteristics similar to the fibrocytes that represent a novel MDSC subset
- (2015) Gurcan Gunaydin et al. OncoImmunology
- Immunological metagene signatures derived from immunogenic cancer cell death associate with improved survival of patients with lung, breast or ovarian malignancies: A large-scale meta-analysis
- (2015) Abhishek D. Garg et al. OncoImmunology
- A century of oncolysis evolves into oncolytic immunotherapy
- (2015) O. Hemminki et al. OncoImmunology
- Opposing effects of immunotherapy in melanoma using multisubtype interferon-alpha – can tumor immune escape after immunotherapy accelerate disease progression?
- (2015) Örjan Strannegård et al. OncoImmunology
- Retargeted oncolytic viruses provoke tumor-directed T-cell responses
- (2015) Arnold Kloos et al. OncoImmunology
- Enhanced neutrophil activity is associated with shorter time to tumor progression in glioblastoma patients
- (2015) Afsar Rahbar et al. OncoImmunology
- Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC
- (2015) Benjamin Besse et al. OncoImmunology
- Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy
- (2015) Jonathan Pol et al. OncoImmunology
- Favorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccination
- (2015) Kalijn F Bol et al. OncoImmunology
- Repeated intratumoral administration of ONCOS-102 leads to systemic antitumor CD8+T-cell response and robust cellular and transcriptional immune activation at tumor site in a patient with ovarian cancer
- (2015) L Vassilev et al. OncoImmunology
- Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients
- (2015) Neil L Berinstein et al. OncoImmunology
- Gastric cancer cells inhibit natural killer cell proliferation and induce apoptosis via prostaglandin E2
- (2015) Tuanjie Li et al. OncoImmunology
- The antitumor immune response generated by fractionated radiation therapy may be limited by tumor cell adaptive resistance and can be circumvented by PD-L1 blockade
- (2015) S J Dovedi et al. OncoImmunology
- Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy
- (2015) Ilkka Liikanen et al. OncoImmunology
- Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing
- (2015) Sofia R. Gameiro et al. Oncotarget
- Classification of current anticancer immunotherapies
- (2015) Lorenzo Galluzzi et al. Oncotarget
- Survival, Efficacy, and Safety of Small Versus Large Doxorubicin Drug-Eluting Beads TACE Chemoembolization in Patients With Unresectable HCC
- (2014) Hasmukh J. Prajapati et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Frontline low-dose alemtuzumab with fludarabine and cyclophosphamide prolongs progression-free survival in high-risk CLL
- (2014) C. H. Geisler et al. BLOOD
- Docetaxel plus oral metronomic cyclophosphamide: A phase II study with pharmacodynamic and pharmacogenetic analyses in castration-resistant prostate cancer patients
- (2014) Lisa Derosa et al. CANCER
- Phase 1 study of oral abexinostat, a histone deacetylase inhibitor, in combination with doxorubicin in patients with metastatic sarcoma
- (2014) Edwin Choy et al. CANCER
- CAR T Cells for Solid Tumors
- (2014) Sunitha Kakarla et al. CANCER JOURNAL
- Novel Mechanism of Macrophage-Mediated Metastasis Revealed in a Zebrafish Model of Tumor Development
- (2014) J. Wang et al. CANCER RESEARCH
- Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
- (2014) M.-G. Anitei et al. CLINICAL CANCER RESEARCH
- Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death
- (2014) Carolien A. Koks et al. INTERNATIONAL JOURNAL OF CANCER
- Galectin-9 Increases Tim-3+ Dendritic Cells and CD8+ T Cells and Enhances Antitumor Immunity via Galectin-9-Tim-3 Interactions
- (2014) K. Nagahara et al. JOURNAL OF IMMUNOLOGY
- Functional Comparison of Engineered T Cells Carrying a Native TCR versus TCR-like Antibody–Based Chimeric Antigen Receptors Indicates Affinity/Avidity Thresholds
- (2014) Ravit Oren et al. JOURNAL OF IMMUNOLOGY
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- (2014) Matthew M. Gubin et al. NATURE
- Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
- (2014) Mahesh Yadav et al. NATURE
- Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
- (2014) Antonella Sistigu et al. NATURE MEDICINE
- Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
- (2014) D. Zamarin et al. Science Translational Medicine
- Therapeutic Implications of Immunogenic Cell Death in Human Cancer
- (2014) Fabio Palombo et al. Frontiers in Immunology
- Consensus guidelines for the detection of immunogenic cell death
- (2014) Oliver Kepp et al. OncoImmunology
- A Single-Arm, Nonrandomized Phase II Trial of Neoadjuvant Gemcitabine and Oxaliplatin in Patients With Resectable Pancreas Adenocarcinoma
- (2013) Eileen M. OʼReilly et al. ANNALS OF SURGERY
- ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death
- (2013) Abhishek D. Garg et al. Autophagy
- Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemia
- (2013) P. Abrisqueta et al. BLOOD
- Panitumumab in combination with infusional oxaliplatin and oral capecitabine for conversion therapy in patients with colon cancer and advanced liver metastases
- (2013) Francesco Leone et al. CANCER
- A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer
- (2013) Edward J. Kim et al. CANCER
- Long-term cardiac safety and outcomes of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel and trastuzumab with and without lapatinib in patients with early breast cancer
- (2013) Patrick G. Morris et al. CANCER
- TLR8 stimulation enhances cetuximab-mediated natural killer cell lysis of head and neck cancer cells and dendritic cell cross-priming of EGFR-specific CD8+ T cells
- (2013) Ryan M. Stephenson et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Danger signalling during cancer cell death: origins, plasticity and regulation
- (2013) A D Garg et al. CELL DEATH AND DIFFERENTIATION
- Molecular mechanisms of ATP secretion during immunogenic cell death
- (2013) I Martins et al. CELL DEATH AND DIFFERENTIATION
- From the immune contexture to the Immunoscore: the role of prognostic and predictive immune markers in cancer
- (2013) Helen Angell et al. CURRENT OPINION IN IMMUNOLOGY
- Antigen Availability Determines CD8+ T Cell-Dendritic Cell Interaction Kinetics and Memory Fate Decisions
- (2013) Sarah E. Henrickson et al. IMMUNITY
- Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death
- (2013) James W. Hodge et al. INTERNATIONAL JOURNAL OF CANCER
- Discovery of chemotherapy-associated ovarian cancer antigens by interrogating memory T cells
- (2013) Marino Paroli et al. INTERNATIONAL JOURNAL OF CANCER
- Peptidases released by necrotic cells control CD8+ T cell cross-priming
- (2013) Jaba Gamrekelashvili et al. JOURNAL OF CLINICAL INVESTIGATION
- Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
- (2013) Jérôme Galon et al. JOURNAL OF PATHOLOGY
- 5-Year Outcome of a Randomized Prospective Study Comparing bacillus Calmette-Guérin with Epirubicin and Interferon-α2b in Patients with T1 Bladder Cancer
- (2013) Tammer Hemdan et al. JOURNAL OF UROLOGY
- Bleomycin Exerts Ambivalent Antitumor Immune Effect by Triggering Both Immunogenic Cell Death and Proliferation of Regulatory T Cells
- (2013) Hélène Bugaut et al. PLoS One
- CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer
- (2013) S. Loi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ménage à Trois in stress: DAMPs, redox and autophagy
- (2013) Guanqiao Li et al. SEMINARS IN CANCER BIOLOGY
- Strange attractors: DAMPs and autophagy link tumor cell death and immunity
- (2013) W Hou et al. Cell Death & Disease
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Long-term neurotoxicity effects of oxaliplatin added to fluorouracil and leucovorin as adjuvant therapy for colon cancer: Results from National Surgical Adjuvant Breast and Bowel Project trials C-07 and LTS-01
- (2012) Kelley M. Kidwell et al. CANCER
- Tissue Damage-Associated "Danger Signals" Influence T-cell Responses That Promote the Progression of Preneoplasia to Cancer
- (2012) Y. He et al. CANCER RESEARCH
- Phagocytosis of apoptotic cells by macrophages in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis
- (2012) S. M. Ohlsson et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
- (2012) Abhishek D Garg et al. EMBO JOURNAL
- Modification of a Tumor Antigen Determinant To Improve Peptide/MHC Stability Is Associated with Increased Immunogenicity and Cross-Priming a Larger Fraction of CD8+ T Cells
- (2012) A. M. Watson et al. JOURNAL OF IMMUNOLOGY
- Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes
- (2012) S. E. Lipshultz et al. PEDIATRICS
- Primary Effusion Lymphoma Cell Death Induced by Bortezomib and AG 490 Activates Dendritic Cells through CD91
- (2012) Mara Cirone et al. PLoS One
- An Immunosurveillance Mechanism Controls Cancer Cell Ploidy
- (2012) L. Senovilla et al. SCIENCE
- Cardiac Glycosides Exert Anticancer Effects by Inducing Immunogenic Cell Death
- (2012) L. Menger et al. Science Translational Medicine
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death
- (2011) S. Serra et al. BLOOD
- Human Tumor Cells Killed by Anthracyclines Induce a Tumor-Specific Immune Response
- (2011) J. Fucikova et al. CANCER RESEARCH
- TGF 1 Inhibition Increases the Radiosensitivity of Breast Cancer Cells In Vitro and Promotes Tumor Control by Radiation In Vivo
- (2011) F. Bouquet et al. CLINICAL CANCER RESEARCH
- Strategies to counteract MHC-I defects in tumors
- (2011) Margit H Lampen et al. CURRENT OPINION IN IMMUNOLOGY
- Cell Death in the Maintenance and Abrogation of Tolerance: The Five Ws of Dying Cells
- (2011) Thomas S. Griffith et al. IMMUNITY
- Cutting Edge: Mouse CD300f (CMRF-35-Like Molecule-1) Recognizes Outer Membrane-Exposed Phosphatidylserine and Can Promote Phagocytosis
- (2011) S.-C. Choi et al. JOURNAL OF IMMUNOLOGY
- Induction of Immunogenic Apoptosis by Blockade of Epidermal Growth Factor Receptor Activation with a Specific Antibody
- (2011) Greta Garrido et al. JOURNAL OF IMMUNOLOGY
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- The Indoleamine-2,3-Dioxygenase (IDO) Inhibitor 1-Methyl-D-tryptophan Upregulates IDO1 in Human Cancer Cells
- (2011) Christiane A. Opitz et al. PLoS One
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation
- (2010) K. Birkholz et al. BLOOD
- Immature Immunosuppressive CD14+HLA-DR−/low Cells in Melanoma Patients Are Stat3hi and Overexpress CD80, CD83, and DC-Sign
- (2010) Isabel Poschke et al. CANCER RESEARCH
- Cyclophosphamide Synergizes with Type I Interferons through Systemic Dendritic Cell Reactivation and Induction of Immunogenic Tumor Apoptosis
- (2010) G. Schiavoni et al. CANCER RESEARCH
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Evidence for a TCR Affinity Threshold Delimiting Maximal CD8 T Cell Function
- (2010) D. A. Schmid et al. JOURNAL OF IMMUNOLOGY
- Pannexin 1 channels mediate ‘find-me’ signal release and membrane permeability during apoptosis
- (2010) Faraaz B. Chekeni et al. NATURE
- Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress
- (2010) I Martins et al. ONCOGENE
- Intravascular Danger Signals Guide Neutrophils to Sites of Sterile Inflammation
- (2010) B. McDonald et al. SCIENCE
- Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti-CTLA-4 Antibody
- (2009) M. Z. Dewan et al. CLINICAL CANCER RESEARCH
- Antigenic profiles of individual-matched pairs of primary and melanoma metastases
- (2009) Clifton B. Meije et al. HUMAN PATHOLOGY
- Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance
- (2009) Michael R. Elliott et al. NATURE
- Cyclophosphamide and cancer: golden anniversary
- (2009) Ashkan Emadi et al. Nature Reviews Clinical Oncology
- Expression of Costimulatory Ligand CD70 on Steady-State Dendritic Cells Breaks CD8+ T Cell Tolerance and Permits Effective Immunity
- (2008) Anna M. Keller et al. IMMUNITY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now